References
WHAT PEOPLE SAY
Prof. SERGE LUQUET, Université Paris Cité
"My research team is primarily focused on the physiology of body weight homeostasis and food intake. A strong component of our work encompass physiological approaches of brain circuits dictating metabolic control. With the emergence of omics technology it has become crucial to benefit from an expertise in bio informatics. My encounter with MedInsights was a revelation in that regards because the company not only has cutting edge knowledge and tools but also-which is quite unique in my experience-is offering mentoring and training support for post-doc and fellows to develop an understanding of the pipeline of analysis and procedure to be followed. MedInsights has been giving talks in my lab on several occasion and we are now actively seeking to make MedInsights part of of all our developing projects in which their expertise and knowledge has become a crucial determinant of competitivity in academic publication, data analysis and fund raising."
ELENI SIOPI, Ph.D., Pharm.D, Institut Necker Enfants Malades
"Very satisfied with our collaboration, I recommend without hesitation"
MARINA LOCHHEAD, Ph.D., Senior Scientist, Kyron bio
"Great at facilitating ongoing communication and quick turnaround on responding to feedback. Very good customer service."
We thank everyone who trusted us...
Our scientific portfolio
Gut microbiota changes require vagus nerve integrity to promote depressive-like behaviors in mice
Chronic stress constitutes a major risk factor for depression that can disrupt various aspects of homeostasis, including the gut microbiome (GM). Our research shows that vagotomy abrogates adult HPC neurogenesis deficits, neuroinflammation and depressive-like behavior, suggesting that vagal afferent pathways are necessary to drive GM-mediated effects on the brain.
Modeling of SARS-CoV-2 Virus Proteins: Implications on Its Proteome.
COronaVIrus Disease 19 (COVID-19) is a severe acute respiratory syndrome (SARS) caused by a group of beta coronaviruses, SARS-CoV-2. The SARS-CoV-2 virus is similar to previous SARS- and MERS-causing strains and has infected nearly six hundred and fifty million people all over the globe, while the death toll has crossed the six million mark (as of December, 2022). In this chapter, we look at how computational modeling approaches of the viral proteins could help us understand the various processes in the viral life cycle inside the host, an understanding of which might provide key insights in mitigating this and future threats. This understanding helps us identify key targets for the purpose of drug discovery and vaccine development.
SARS- CoV-2 viroporins:
A multi-omics insight from nucleotides to amino acids
The study of two prominent viroporins of SARS-CoV-2: Orf3a and (E) protein from a sequential and structural point of view.
Structural insight into the role of novel SARS-CoV-2 E protein: A potential target for vaccine development and other therapeutic strategies
Using the bioinformatics and structural modelling approach, we modelled the structure of the envelope (E)-protein of novel SARS-CoV-2, and propose that it plays a critical role in viral infection and pathogenesis.